ReviewFrontiers in pharmacology2025

Current insights and prospects for the pathogenesis and treatment of clinical manifestations associated with Down syndrome through neurotransmitter, inflammatory, and oxidative stress pathways.

Fawaz Alasmari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.